These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10160470)

  • 81. Complicated migraine and migraine variants.
    Rothner AD
    Semin Pediatr Neurol; 2001 Mar; 8(1):7-12. PubMed ID: 11332867
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Treatment of childhood headache with dihydroergotamine mesylate.
    Linder SL
    Headache; 1994; 34(10):578-80. PubMed ID: 7843951
    [TBL] [Abstract][Full Text] [Related]  

  • 83. STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD
    Smith TR; Winner P; Aurora SK; Jeleva M; Hocevar-Trnka J; Shrewsbury SB
    Headache; 2021 Sep; 61(8):1214-1226. PubMed ID: 34363701
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Costs of hypothalamic stimulation in chronic drug-resistant cluster headache: preliminary data.
    Leone M; Franzini A; Cecchini AP; Mea E; Broggi G; Bussone G
    Neurol Sci; 2009 May; 30 Suppl 1():S43-7. PubMed ID: 19415425
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.
    Saper JR; Silberstein S
    Headache; 2006 Nov; 46 Suppl 4():S171-81. PubMed ID: 17078849
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Subcutaneous dihydroergotamine vs subcutaneous sumatriptan.
    Catarci T; Cerbo R
    Arch Neurol; 1996 Dec; 53(12):1215-6. PubMed ID: 8970446
    [No Abstract]   [Full Text] [Related]  

  • 87. A new dihydroergotamine nasal spray (Trudhesa) for migraine.
    Med Lett Drugs Ther; 2021 Dec; 63(1640):204-207. PubMed ID: 35100240
    [No Abstract]   [Full Text] [Related]  

  • 88. MT 300--POZEN: dihydroergotamine mesylate injection.
    Drugs R D; 2003; 4(6):376-7. PubMed ID: 14584970
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action.
    Cooper W; Ray S; Aurora SK; Shrewsbury SB; Fuller C; Davies G; Hoekman J
    J Aerosol Med Pulm Drug Deliv; 2022 Dec; 35(6):321-332. PubMed ID: 36108289
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Development and in vitro/in vivo evaluation of dihydroergotamine mesylate loaded maltodextrin-pullulan sublingual films.
    Esim O; Ozkan CK; Kurbanoglu S; Arslan A; Tas C; Savaser A; Ozkan SA; Ozkan Y
    Drug Dev Ind Pharm; 2019 Jun; 45(6):914-921. PubMed ID: 30714426
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Sumatriptan: a clinical standard?
    Stratton SJ
    Ann Emerg Med; 1995 Apr; 25(4):538-9. PubMed ID: 7710163
    [No Abstract]   [Full Text] [Related]  

  • 92. DHE-45 for acute migraine.
    Hagen N; Portenoy RK; Foley KM
    Neurology; 1989 Oct; 39(10):1408-9. PubMed ID: 2677838
    [No Abstract]   [Full Text] [Related]  

  • 93. Onset of neurologic deficits after treatment with dihydroergotamine in a patient with sagittal sinus thrombosis.
    Evans MS; Naritoku DK; Couch JR; Ghobrial MW
    Clin Neuropharmacol; 1996 Apr; 19(2):177-84. PubMed ID: 8777772
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Claudication: an unusual side effect of DHE administration.
    Schulman EA; Rosenberg SB
    Headache; 1991 Apr; 31(4):237-9. PubMed ID: 2050518
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Winning a sweepstakes does not cure migraine.
    Evans RW
    Headache; 1995 Mar; 35(3):169. PubMed ID: 7721581
    [No Abstract]   [Full Text] [Related]  

  • 96. Everything old is new again.
    Freitag FG
    Headache; 2021 Sep; 61(8):1286. PubMed ID: 34350590
    [No Abstract]   [Full Text] [Related]  

  • 97. Development and Evaluation of an Integrated Outpatient Infusion Care Model for the Treatment of Pediatric Headache.
    Shapiro HFJ; Sant J; Minster A; Antonelli RC
    Pediatr Neurol; 2022 Feb; 127():41-47. PubMed ID: 34959159
    [TBL] [Abstract][Full Text] [Related]  

  • 98. In-patient treatment of chronic daily headache using dihydroergotamine: a long-term follow-up study.
    Pringsheim T; Howse D
    Can J Neurol Sci; 1998 May; 25(2):146-50. PubMed ID: 9604137
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [First clinical experience with dihydroergotamine (DHE 45)].
    IMFELD JP
    Schweiz Med Wochenschr; 1946 Dec; 76(49):1263-6. PubMed ID: 20296721
    [No Abstract]   [Full Text] [Related]  

  • 100. Intravenous DHE and cost saving.
    Robbins L
    Headache; 1995 Jan; 35(1):50. PubMed ID: 7868336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.